[Significance of disorders of hemoglobin synthesis for the clinical practice].
D000748:Anemia, Macrocytic / Q000378:metabolism / Q000628:therapy; D000755:Anemia, Sickle Cell; D003676:Deferoxamine / Q000627:therapeutic use; D004905:Erythrocyte Aging; D004920:Erythropoiesis; D006402:Hematologic Diseases; D006418:Heme / Q000096:biosynthesis; D006453:Hemoglobinopathies / Q000188:drug therapy; D006454:Hemoglobins / Q000096:biosynthesis*; D006455:Hemoglobins, Abnormal; D006801:Humans; D008708:Methemoglobinemia; D008928:Mitochondria; D010452:Peptide Biosynthesis
D006454:Hemoglobins; D006455:Hemoglobins, Abnormal; D006418:Heme; D003676:Deferoxamine
Die Bedeutung von Störungen der Hämoglobinsynthese für die Klinik.